Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 3/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 10/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | FABP2 | P12104 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.49 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.49 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31117047 | 1.00 | HIF1A (0.50) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL8142507 | 1.00 | HIF1A (0.50) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL31415015 | 1.00 | HIF1A (0.50) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL8142511 | 1.00 | HIF1A (0.50) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL12800395 | 0.88 | HIF1A (0.48) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL15695564 | 0.88 | HIF1A (0.48) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL6491103 | 0.86 | CES2 (0.51) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL27711080 | 0.85 | HIF1A (0.49) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL11153495 | 0.85 | PTGS2 (0.49) | HIF1APTGS2PTGS1MEN1KMT2A | |
| SCHEMBL2204495 | 0.84 | PTGS2 (0.56) | HIF1APTGS2PTGS1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108456140-B | Method for preparing flurbiprofen impurity M | 心邀（深圳）生物科技有限公司 | 2021-06-11 | — | — | CN | claimed |
| EP-2799424-B1 | 2-FLUOROPHENYLPROPIONIC ACID DERIVATIVE | LTT BIO PHARMA CO LTD (JP) | 2016-08-17 | — | — | EP | claimed |
| US-9221786-B2 | 2-fluorophenyl propionic acid derivatives | LTT BIO-PHARMA CO., LTD. (JP) | 2015-12-29 | — | — | US | claimed |
| US-20140330026-A1 | 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES | LTT BIO-PHARMA CO., LTD. (JP) | 2014-11-06 | — | — | US | claimed |
| EP-2799424-A1 | 2-FLUOROPHENYLPROPIONIC ACID DERIVATIVE | LTT Bio-Pharma Co., Ltd. (JP) | 2014-11-05 | — | — | EP | claimed |
| CN-101380317-A | Pharmaceutical composition for relieving pruritus | CAYMAN ISLAND SHANGANSHENG DEV (CN) | 2009-03-11 | — | — | CN | claimed |
| US-4411974-A | FOR NEGATIVE TONERS | XEROX CORPORATION (US) | 1983-10-25 | — | — | US | claimed |
| US-4367176-A | Esters of arylpropionic acids endowed with an anti-inflammatory activity and related pharmaceutical compositions | AUSONIA FARMACEUTICI S.R.L. (IT) | 1983-01-04 | — | — | US | claimed |
| JP-57009757-A | — | — | None | — | — | JP | disclosed |
| JP-8253440-A | — | — | None | — | — | JP | disclosed |
| US-12605351-B2 | Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis | LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LU) | 2026-04-21 | — | — | US | disclosed |
| EP-4682141-A1 | TRICYCLIC COMPOUND | ONO Pharmaceutical Co., Ltd. (JP) | 2026-01-21 | — | — | EP | disclosed |
| WO-2025074305-A1 | N-(1-(AMINOMETHYL)CYCLOPROPYL)(ARYL OR HETEROARYL) CARBOXAMIDE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-04-10 | — | — | WO | disclosed |
| CN-119639276-A | Ink composition, semiconductor nanoparticle-polymer composite prepared therefrom, electronic device, and display device | 三星电子株式会社 | 2025-03-18 | — | — | CN | disclosed |
| JP-H08253440-A | PREPARATION OF ENANTIOMER OF 2-(2-FLUORO-4BIPHENYL) PROPIONIC ACID | ZAMBON GROUP SPA | 1996-10-01 | — | — | JP | disclosed |
| EP-0712387-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1996-05-22 | — | — | EP | disclosed |
| WO-1995004713-A1 | 2-AMINOINDANS AS SELECTIVE DOPAMINE D3 LIGANDS | THE UPJOHN COMPANY (US) | 1995-02-16 | — | — | WO | disclosed |
| US-4411974-A | FOR NEGATIVE TONERS | XEROX CORPORATION (US) | 1983-10-25 | — | — | US | disclosed |
| JP-S579757-A | ALPHA-SULFONYL 2-FLUORO-4-BIPHENYLYL ACETIC ACID DERIVATIVE | SAGAMI CHEM RES CENTER | 1982-01-19 | — | — | JP | disclosed |
| US-4008270-A | Process for preparing 2-(substituted phenyl)propionic acids | THE UPJOHN COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605351-B2 | Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis | NFATC1, CYP51A1, ME1 | HIF1A 1661/4885PTGS2 1657/4885PTGS1 1096/4885 |
| US-20140330026-A1 | 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES | FPR1, OPRK1, FPR2 | HIF1A 395/4885PTGS2 127/4885PTGS1 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.